Burlingame, CA, United States of America

Reza Oliyai

USPTO Granted Patents = 22 


 

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 599(Granted Patents)


Location History:

  • San Ramon, CA (US) (2000)
  • San Carlos, CA (US) (2010 - 2015)
  • Foster City, CA (US) (1999 - 2017)
  • Burlingame, CA (US) (2013 - 2023)

Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Reza Oliyai: Innovator in Antiviral Pharmaceutical Formulations

Introduction

Reza Oliyai is a prominent inventor based in Burlingame, California, with an impressive portfolio of 22 patents to his name. His work primarily focuses on pharmaceutical compositions, particularly in the field of antiviral compounds. Reza's contributions significantly impact the development of effective treatment options in the medical field.

Latest Patents

Among his latest innovations, Reza has disclosed a combination formulation of two antiviral compounds. This patent features pharmaceutical compositions that include a specific compound known as Compound I, alongside an effective amount of sofosbuvir, which is presented in a substantially crystalline form. Additionally, his patents outline various methods of use for these pharmaceutical compositions, showcasing his commitment to advancing antiviral therapies.

Career Highlights

Reza has held pivotal roles at notable companies in the pharmaceutical industry, including Gilead Sciences, Inc. and Gilead Pharmasset LLC. His experience in these organizations has enabled him to collaborate on groundbreaking research and product development, leading to significant advancements in antiviral medications.

Collaborations

Throughout his career, Reza has worked alongside esteemed colleagues such as Terrence C. Dahl and Vahid Zia. These collaborations have been instrumental in driving innovation within the field, allowing them to combine their expertise to develop effective therapeutic solutions.

Conclusion

In conclusion, Reza Oliyai stands out as a key figure in the realm of antiviral drug development. With 22 patents and a strong background in leading pharmaceutical companies, his work continues to shape the future of healthcare. Through his innovative formulations and collaborative efforts, Reza is making a lasting impact on the fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…